Preview

Modern Rheumatology Journal

Advanced search

Treatment for rheumatic polymyalgia

https://doi.org/10.14412/1996-7012-2013-2371

Abstract

Glucocorticosteroids (GCs) that provide a good and rapid clinical effect are the drug of choice to treat rheumatic polymyalgia (RP). A review of English language publications on the treatment of RP is given. Thirty (13 randomized and 17 observational) studies of 20 and more patients with RP have been analyzed. Particular emphasis is laid on initial therapy with GCs, evaluation of their different daily doses, schemes for their dosage reduction and treatment termination, and on the frequency of recurrences. Studies dealing with the treatment with prednisone, prednisolone, methylprednisolone, and injectable sustained-release GC formulations are considered. The data of clinical trials of glucocorticoid-sparing agents (methotrexate, azathioprine) during early and maintenance therapy are analyzed. The genetically engineered agents (infliximab, etanercept) investigated in clinical trials are considered to be as alternatives; a case of using rituximab is described. The role of nonsteroidal anti-inflammatory drugs in the treatment of RP is also evaluated. An algorithm is proposed for the management of a patient with RP.

References

1. <div><p>Salvarani C., Cantini F., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008;372(9634):234-45.</p><p>Salvarani C., Cantini F., Boiardi L., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347(4):261—71.</p><p>Бунчук Н.В. Ревматическая полимиалгия. В кн.: Н.В. Бунчук. Ревматические заболевания пожилых. М.: МЕДпресс-информ, 2010;87—135.</p><p>Meliconi R., Pulsatelli L., Uguccioni M. et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica: quantitative analysis and influence of corticosteroid treatment. Arthr Rheum 1996;39:1199-207.</p><p>Salvarani C., Cantini F., Olivieri I. et al. Proximal bursitis in active polymyalgia rheumatica. Ann Int Med 1997;127:27-31.</p><p>Cantini F., Salvarani C., Olivieri I. et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheum 2001;28:1049-55.</p><p>Cantini F., Niccoli L., Nannini C. et al. Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheum 2005;23:462-8.</p><p>Salvarani C., Barozzi L., Cantini F. et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 2008;67:758-61.</p><p>Gonzalez-Gay M.A., Garcia-Porrua C., Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheum 1998;25:1750-5.</p><p>Gonzalez-Gay M.A. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthr Rheum 2004;33:289-93.</p><p>Gonzalez-Gay M.A., Barros S., Lopez-Diaz M.J. et al. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Baltimore: Medicine, 2005;84:269-76.</p><p>Maradit-Kremers H., Nicola P.J., Crowson C.S. et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthr Rheum 2005;52:722-32.</p><p>Warrington K.J., Jarpa E.P., Crowson C.S. et al. Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study. Arthr Res Ther 2009;11(2):R50.</p><p>Barber H.S. Myalgic syndrome with constitutional effect: polymyalgia rheumatic. Ann Rheum Dis 1957;16:207-37.</p><p>Healey L.A. Long-term follow-up of polymyalgia rheumatica: evidence of synovitis. Semin Arthr Rheum 1984;13:322-8.</p><p>Bird H.A., Esselinckx W., Dixon A.S. et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38(5):434-9.</p><p>Jones J.G., Hazleman B.L. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40(1):1-5.</p><p>Chuang T.Y., Hunder G.G., Ilstrup D.M., Kurland L.T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.</p><p>Bird H.A., Leeb B.F., Montecucco C.M. et al. European collaborating PMR group. A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 2005;64:626-9.</p><p>Hart F.D. Polymyalgia rheumatica. Br Med J 1969;2(5649):99-100.</p><p>Hernandez-Rodriguez J., Font C., Garcia-Martinez A. et al. Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients. Baltimore: Medicine, 2007;86(4):233-41.</p><p>Angeli A., Guglielmi G., Dovio A. et al. High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a crosssectional outpatient study. Bone 2006;39(2):253-9.</p><p>Hernandez-Rodriguez J., Cid M.C., Lopez-Soto A. et al, Treatment of Polymyalgia Rheumatica. A SystematicReview. Arch Int Med 2009;169(20):1839-50.</p><p>Caporali R., Cimmino M.A., Ferraccioli G. et al. Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Int Med 2004;141(7):493-500.</p><p>Salvarani C., Macchioni P., Manzini C. et al. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Int Med 2007;146(9):631-9.</p><p>Gonzalez-Gay M.A., Garcia-Porrua C., Vazquez-Caruncho M. et al. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheum 1999;26(6):1326-32.</p><p>Narvaez J., Nolla-Sole J.M., Clavaguera M.T. et al. Long-term therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheum 1999;26(9):1945-52.</p><p>Kremers H.M., Reinalda M.S., Crowson C.S. et al. Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheum 2005;32(1):65—73.</p><p>Fauchald P., Rygvold O., Oystese B. Temporal arteritis and polymyalgia rheumatica: clinical and biopsy findings. Ann Int Med 1972;77(6):845-52.</p><p>Gabriel S.E., Sunku J., Salvarani C. et al. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthr Rheum 1997;40(10):1873-8.</p><p>Spiera H., Davison S. Long-term follow-up of polymyalgia rheumatica. Mt Sinai J Med 1978;45(2):225-9.</p><p>Hutchings A., Hollywood J., Lamping D.L. et al. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthr Rheum 2007;57(5):803-9.</p><p>Cimmino M.A., Parodi M., Caporali R., Montecucco C. Is the course of steroid-treated polymyalgia rheumatica more severe in women? Ann NY Acad Sci 2006;1069:315-21.</p><p>Mowat A.G., Camp A.V. Polymyalgia rheumatica. J Bone Joint Surg Br 1971;53(4):701-10.</p><p>Delecoeuillerie G., Joly P., Cohen de Lara A., Paolaggi J.B. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 1988;47(9):733-9.</p><p>Ayoub W.T., Franklin C.M., Torretti D. Polymyalgia rheumatica: duration of therapy and long-term outcome. Am J Med 1985;79(3):309-15.</p><p>Weyand C.M., Fulbright J.W., Evans J.M. et al. Corticosteroid requirements in polymyalgia rheumatica. Arch Int Med 1999;159(6):577-84.</p><p>Behn A.R., Perera T., Myles A.B. Polymyalgia rheumatica and corticosteroids: how much for how long? Ann Rheum Dis 1983;42(4):374-8.</p><p>Myklebust G., Gran J.T. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis: a prospective two-year study in 273 patients. Scand J Rheum 2001;30(5):260-7.</p><p>Cimmino M.A., Moggiana G., Montecucco C. et al. Long-term treatment of polymyalgia rheumatic with deflazacort. Ann Rheum Dis 1994;53(5):331—3.</p><p>Lund B., Egsmose C., Jorgensen S., Krogsgaard M.R. Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica. Calcif Tissue Int 1987;41(6):316—20.</p><p>Di Munno O., Imbimbo B., Mazzantini M. et al. Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens. J Rheum1995;22(8):1492-8.</p><p>Krogsgaard M.R., Lund B., Johnsson B. A long-term prospective study of the equipotency between deflazacort and prednisolone in the treatment of patients with polymyalgia rheumatica. J Rheum 1995;22(9):1660-2.</p><p>Dasgupta B., Dolan A.L., Panayi G.S., Fernandes L. An initially double-blind controlled 96-week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br J Rheum 1998;37(2):189—95.</p><p>Salvarani C., Cantini F., Olivieri I. et al. Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study. J Rheum 2000;27(6):1470-6.</p><p>Vander Veen M.J., Dinant H.J., van Booma-Frankfort C. et al. Can methotrexate be used as a steroid-sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 1996;55(4):218-23.</p><p>Caporali R., Cimmino M.A., Ferraccioli G. et al. Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Int Med 2004;141(7):493-500.</p><p>Ferraccioli G., Salaffi F., De Vita S. et al. Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheum 1996;23(4):624-8.</p><p>Cimmino M.A., Salvarani C., Macchioni P. et al, Systemic Vasculitis Study Group of the Italian Society for Rheumatology. Longterm follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids. Clin Exp Rheum 2008;26(3):395-400.</p><p>Feinberg H.L., Sherman J.D., Schrepferman C.G. et al. The use of methotrexate in polymyalgia rheumatica. J Rheum 1996;23(9):1550-2.</p><p>De Silva M., Hazleman B.L. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 1986;45(2):136-8.</p><p>Salvarani C., Macchioni P., Manzini C. et al. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Int Med 2007;146(9):631-9.</p><p>Mowat A.G., Camp A.V. Polymyalgia rheumatica. J Bone Joint Surg Br 1971;53(4):701-10.</p><p>Littman B.H., Bjarnason D., Bryant G. et al. Steroid-sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double-blind randomized placebo-controlled study. J Rheum 1995;22(6):1097-103.</p><p>Kyle V., Hazleman B.L. Treatment of polymyalgia rheumatica and giant cell arteritis I: steroid regimens in the first two months. Ann Rheum Dis 1989;48(8):658—61.</p><p>Kyle V., Hazleman B.L. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment. Ann Rheum Dis 1993;52(12):847-50.</p><p>Wegrzyn J., Adeleine P., Miossec P. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis. Ann Rheum Dis 2004;63(10):1232-4.</p><p>Braun J., Kastner P., Flaxenberg P. et al. MC-MTX.6/RH Study Group. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthr Rheum 2008;58(1):73-81.</p><p>Kreiner F., Galbo H. Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial. Arthr Res Ther 2010;12(5):R176.</p><p>Braunert L., Bruegel M., Pfrepper C. et al. Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica. Hеmostaseologie 2010;30 (Suppl 1):S40-3.</p><p>Seitz M., Reichenbach S., Bonel H.M. et al. Rapid induction of remission in large-vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 2011;141: 13156. doi: 10.4414/smw.2011.13156.</p><p>Dasgupta B., Salvarani C., Schirmer M. et al. members of the American College of Rheumatology Work Group for Development of Classification Criteria for PMR. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheum 2008;35(2):270-7.</p></div><br />


Review

For citations:


Satybaldyev AM. Treatment for rheumatic polymyalgia. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2013;7(1):66-72. (In Russ.) https://doi.org/10.14412/1996-7012-2013-2371

Views: 6137


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)